Lung Cancer in Israel

Roxana D. Grinberg; Yael Refaely; Liora Boehm Cohen; Dorith Shaham; Elizabeth Dudnik; Rephael Pfeffer; Aaron Allen; Nir Peled

doi:10.1016/j.jtho.2020.01.022

Lung Cancer in Israel

Roxana D. Grinberg, Yael Refaely, Liora Boehm Cohen, Dorith Shaham, Elizabeth Dudnik, Rephael Pfeffer, Aaron Allen, Nir Peled^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	493-498
Number of pages	6
Journal	Journal of Thoracic Oncology
Volume	15
Issue number	4
DOIs	https://doi.org/10.1016/j.jtho.2020.01.022
State	Published - Apr 2020
Externally published	Yes

Bibliographical note

Funding Information:
Disclosure: Dr. Dudnik reports grants and personal fees from Roche Holding AG and Boehringer Ingelheim and personal fees from AstraZeneca, Pfizer, Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, and Takeda, outside of the submitted work. Dr. Peled reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche Holding AG, NovellusDx, FMI, and Gaurdant360, outside of the submitted work. The remaining authors declare no conflict of interest.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jtho.2020.01.022

Cite this

@article{6681834690dc424586fbfe2ee8d90c32,

title = "Lung Cancer in Israel",

author = "Grinberg, {Roxana D.} and Yael Refaely and Cohen, {Liora Boehm} and Dorith Shaham and Elizabeth Dudnik and Rephael Pfeffer and Aaron Allen and Nir Peled",

note = "Funding Information: Disclosure: Dr. Dudnik reports grants and personal fees from Roche Holding AG and Boehringer Ingelheim and personal fees from AstraZeneca, Pfizer, Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, and Takeda, outside of the submitted work. Dr. Peled reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche Holding AG, NovellusDx, FMI, and Gaurdant360, outside of the submitted work. The remaining authors declare no conflict of interest.",

year = "2020",

month = apr,

doi = "10.1016/j.jtho.2020.01.022",

language = "אנגלית",

volume = "15",

pages = "493--498",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Lung Cancer in Israel

AU - Grinberg, Roxana D.

AU - Refaely, Yael

AU - Cohen, Liora Boehm

AU - Shaham, Dorith

AU - Dudnik, Elizabeth

AU - Pfeffer, Rephael

AU - Allen, Aaron

AU - Peled, Nir

N1 - Funding Information: Disclosure: Dr. Dudnik reports grants and personal fees from Roche Holding AG and Boehringer Ingelheim and personal fees from AstraZeneca, Pfizer, Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, and Takeda, outside of the submitted work. Dr. Peled reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche Holding AG, NovellusDx, FMI, and Gaurdant360, outside of the submitted work. The remaining authors declare no conflict of interest.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85082562155&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2020.01.022

DO - 10.1016/j.jtho.2020.01.022

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???

C2 - 32216944

AN - SCOPUS:85082562155

SN - 1556-0864

VL - 15

SP - 493

EP - 498

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

Lung Cancer in Israel

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this